Please confirm you are human

This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.

A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.

Hold with a pointer, or hold Space or Enter.

News

via.ritzau.dk
via.ritzau.dk > pressemeddelelse > 15/15/7771 > kvika-banki-hf

Kvika banki hf. | Globenewswire

17+ hour, 8+ min ago   (220+ words) Kvika banki hf.: Jón Birgir Jónsson appointed CEO of Kvika banki The Board of Directors of Kvika banki has appointed Jón Birgir Jónsson as Chief Executive Officer of Kvika banki. Jón Birgir will assume his new role on 1 December 2026, succeeding…...

Via Ritzau
via.ritzau.dk > pressemeddelelse > 15/14/8696 > vallourec

VALLOUREC | Globenewswire

5+ day, 10+ hour ago   (200+ words) VALLOUREC AND ARAMCO STRENGTHEN THEIR PARTNERSHIP THROUGH THE SIGNING OF AN AGREEMENT FOR THE SUPPLY OF OIL COUNTRY TUBULAR GOODS Meudon, France, September 09th, 2026 – Vallourec, a world leader in premium seamless tubular solutions, announces the signing of an agreement with Aramco…...

Via Ritzau
via.ritzau.dk > pressemeddelelse > 15/14/8375 > inventiva

INVENTIVA | Globenewswire

5+ day, 19+ hour ago   (121+ words) Inventiva to Present Multiple Abstracts at Paris MASH 2026 Lanifibranor is currently being evaluated in the Phase 3 NATiV3 clinical trial for the treatment of patients with MASH with moderate and advanced fibrosis, with topline results expected in the fourth quarter of this…...

Via Ritzau
via.ritzau.dk > pressemeddelelse > 15/14/6300 > greywolf-therapeutics

Greywolf Therapeutics | Globenewswire

6+ day, 9+ hour ago   (417+ words) Greywolf Therapeutics doses first participants with axSpA in novel ERAP1 inhibitor trial OXFORD, United Kingdom, Sept. 08, 2026 (GLOBE NEWSWIRE) -- Greywolf Therapeutics, the clinical-stage biotech company advancing novel antigen modulation treatments for cancer and autoimmune diseases, today reports significant progress in their Phase…...

Via Ritzau
via.ritzau.dk > pressemeddelelse > 15/14/6003 > theon-international-plc

THEON International PLC | Globenewswire

6+ day, 20+ hour ago   (303+ words) Publication of H1 2026 Report 07 September 2026 - Theon International Plc (THEON) is pleased to announce the publication of its H1 2026 Report for the six months ended 30 June 2026 which is now available on the IR website. This follows the H1 2026 Trading Update published on 27 July 2026, with…...

Via Ritzau
via.ritzau.dk > pressemeddelelse > 15/14/1802 > iveco-group-nv

Iveco Group N.V. | Globenewswire

1+ week, 2+ day ago   (1398+ words) TATA MOTORS LAUNCHES RECOMMENDED ALL-CASH VOLUNTARY TOTALITARIAN TENDER OFFER FOR IVECO GROUP COMMON SHARES A powerful combination to create a global leader in commercial vehicles The Offeror is making the Offer on the terms and subject to the conditions and…...

Via Ritzau
via.ritzau.dk > pressemeddelelse > 15/13/2517 > fortrea-holdings-inc

Fortrea Holdings Inc | Globenewswire

1+ week, 5+ day ago   (156+ words) Together, the transaction positions both organizations to build on their respective strengths while continuing to support sponsors across the drug development lifecycle. Fortrea and Worldwide intend to enter into a series of agreements to support continuity for customers, employees and…...

Via Ritzau
via.ritzau.dk > pressemeddelelse > 15/13/1269 > lissome

LISSOME | Globenewswire

1+ week, 5+ day ago   (239+ words) LISSOME Enters Europe at IFA 2026 With the R1, a 280 mm-Wide Compact Countertop Dishwasher BERLIN, Sept. 02, 2026 (GLOBE NEWSWIRE) -- LISSOME, a smart kitchen appliance brand focused on intelligent technology and thoughtful design, today announces that it is debuting its flagship dishwasher, the LISSOME…...

Via Ritzau
via.ritzau.dk > pressemeddelelse > 15/12/9732 > alveus-therapeutics-inc

Alveus Therapeutics Inc | Globenewswire

1+ week, 6+ day ago   (163+ words) Company appoints John Stubenrauch, PhD, as Chief Technology Officer and Patrick Garibay, PhD, as Chief Development Officer Xiao-Ping Dai, PhD, stepped down as Chief Technology Officer for personal reasons following a planned transition period with Stubenrauch. During her tenure, Dai…...

Via Ritzau
via.ritzau.dk > pressemeddelelse > 15/12/7906 > atlantic-petroleum-pf

Atlantic Petroleum P/F | Globenewswire

1+ week, 6+ day ago   (271+ words) Atlantic Petroleum – Condensed Consolidated Interim Report – 2nd Quarter 2026 Highlights for Q2 2026: G&A cost was DKK 0.8MMOperating loss was DKK 2.7MMNet loss was DKK 2.9MMEarnings per share DKK -0.78Net assets/share-holders equity was DKK -119.6MM Mark T. Højgaard, CEO commented: The first half of 2026 was dominated by…...